MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 2, Issue 4, Pages e151-e151
Publisher
Springer Nature
Online
2011-04-28
DOI
10.1038/cddis.2011.32
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential
- (2010) E. Ballabio et al. BLOOD
- MicroRNAs meet cell death
- (2010) G Melino et al. CELL DEATH AND DIFFERENTIATION
- Reprogramming of miRNA networks in cancer and leukemia
- (2010) S. Volinia et al. GENOME RESEARCH
- Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer
- (2010) Zhibin Hu et al. JOURNAL OF CLINICAL ONCOLOGY
- Costimulation-Dependent Expression of MicroRNA-214 Increases the Ability of T Cells To Proliferate by Targeting Pten
- (2010) P. T. Jindra et al. JOURNAL OF IMMUNOLOGY
- Genome-Wide Analysis of Cutaneous T-Cell Lymphomas Identifies Three Clinically Relevant Classes
- (2010) Elodie Laharanne et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- MicroRNA-21 Expression in CD4+ T Cells Is Regulated by STAT3 and Is Pathologically Involved in Sézary Syndrome
- (2010) Leslie van der Fits et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Specific Alterations of MicroRNA Transcriptome and Global Network Structure in Colorectal Carcinoma after Cetuximab Treatment
- (2010) M. Ragusa et al. MOLECULAR CANCER THERAPEUTICS
- TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214
- (2010) G Yin et al. ONCOGENE
- MicroRNAs in Cancer
- (2009) Ramiro Garzon et al. Annual Review of Medicine
- How I treat mycosis fungoides and Sezary syndrome
- (2009) H. M. Prince et al. BLOOD
- Identification of Key Regions and Genes Important in the Pathogenesis of Sezary Syndrome by Combining Genomic and Expression Microarrays
- (2009) E. Caprini et al. CANCER RESEARCH
- RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
- (2009) Scott Valastyan et al. CELL
- Origins and Mechanisms of miRNAs and siRNAs
- (2009) Richard W. Carthew et al. CELL
- MicroRNAs as regulators of death receptors signaling
- (2009) M Garofalo et al. CELL DEATH AND DIFFERENTIATION
- Genetic dissection of the miR-17 92 cluster of microRNAs in Myc-induced B-cell lymphomas
- (2009) P. Mu et al. GENES & DEVELOPMENT
- miR-155: On the Crosstalk Between Inflammation and Cancer
- (2009) Esmerina Tili et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis
- (2009) Tetsuya Ueda et al. LANCET ONCOLOGY
- Causes and consequences of microRNA dysregulation in cancer
- (2009) Carlo M. Croce NATURE REVIEWS GENETICS
- Novel and Highly Recurrent Chromosomal Alterations in Sezary Syndrome
- (2008) M. H. Vermeer et al. CANCER RESEARCH
- Emerging Role of miR-106b-25/miR-17-92 Clusters in the Control of Transforming Growth Factor Signaling
- (2008) F. Petrocca et al. CANCER RESEARCH
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- MicroRNAs: new regulators of immune cell development and function
- (2008) David Baltimore et al. NATURE IMMUNOLOGY
- The let-7 family of microRNAs
- (2008) Sarah Roush et al. TRENDS IN CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started